111 related articles for article (PubMed ID: 7309279)
1. Plasma prolactin levels and breast cancer: relation to parity, weight and height, and age at first birth.
Kwa HG; Cleton F; Bulbrook RD; Wang DY; Hayward JL
Int J Cancer; 1981 Jul; 28(1):31-4. PubMed ID: 7309279
[TBL] [Abstract][Full Text] [Related]
2. The permanent effect of reproductive events on blood prolactin levels and its relation to breast cancer risk: a population study of postmenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Hayward JL; Gravelle IH
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1225-31. PubMed ID: 3416905
[TBL] [Abstract][Full Text] [Related]
3. The relationship between blood prolactin levels and risk of breast cancer in premenopausal women.
Wang DY; de Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Verstraeten AA; Moore JW; Fentiman IS; Chaudary M; Hayward JL
Eur J Cancer Clin Oncol; 1987 Oct; 23(10):1541-8. PubMed ID: 3678318
[TBL] [Abstract][Full Text] [Related]
4. Reproductive factors and family history of breast cancer in relation to plasma prolactin levels in premenopausal and postmenopausal women.
Eliassen AH; Tworoger SS; Hankinson SE
Int J Cancer; 2007 Apr; 120(7):1536-41. PubMed ID: 17211859
[TBL] [Abstract][Full Text] [Related]
5. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk.
Kampert JB; Whittemore AS; Paffenbarger RS
Am J Epidemiol; 1988 Nov; 128(5):962-79. PubMed ID: 3189296
[TBL] [Abstract][Full Text] [Related]
6. Nyctohemeral changes in plasma prolactin levels and their relationship to breast cancer risk.
Wang DY; Sturzaker HE; Kwa HG; Verhofstad F; Hayward JL; Bulbrook RD
Int J Cancer; 1984 May; 33(5):629-32. PubMed ID: 6724738
[TBL] [Abstract][Full Text] [Related]
7. Relationship of blood prolactin levels and the risk of subsequent breast cancer.
Wang DY; De Stavola BL; Bulbrook RD; Allen DS; Kwa HG; Fentiman IS; Hayward JL; Millis RR
Int J Epidemiol; 1992 Apr; 21(2):214-21. PubMed ID: 1428472
[TBL] [Abstract][Full Text] [Related]
8. Relation between tumour size and plasma prolactin levels in premenopausal patients with breast carcinoma. A preliminary report.
Olsson H; Ewers SB; Landin-Olsson M; Ranstam J
Acta Radiol Oncol; 1985; 24(1):57-9. PubMed ID: 2984903
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities in evening plasma prolactin levels in nulliparous women with benign or malignant breast disease.
Tarquini A; di Martino L; Malloci A; Kwa HG; van der Gugten AA; Bulbrook RD; Wang DY
Int J Cancer; 1978 Dec; 22(6):687-90. PubMed ID: 721323
[TBL] [Abstract][Full Text] [Related]
10. Prolactin and growth hormone levels in premenopausal women with breast cancer and healthy women with a strong family history of breast cancer.
Love RR; Rose DR; Surawicz TS; Newcomb PA
Cancer; 1991 Sep; 68(6):1401-5. PubMed ID: 1873792
[TBL] [Abstract][Full Text] [Related]
11. An abnormal luteal-phase evening peak of plasma prolactin in women with a family history of breast cancer.
Kwa HG; Wang DY
Int J Cancer; 1977 Jul; 20(1):12-4. PubMed ID: 561758
[TBL] [Abstract][Full Text] [Related]
12. Prolactin and breast cancer risk.
Ingram DM; Nottage EM; Roberts AN
Med J Aust; 1990 Oct; 153(8):469-73. PubMed ID: 2215338
[TBL] [Abstract][Full Text] [Related]
13. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
[TBL] [Abstract][Full Text] [Related]
14. Alcohol, height, and adiposity in relation to estrogen and prolactin levels in postmenopausal women.
Hankinson SE; Willett WC; Manson JE; Hunter DJ; Colditz GA; Stampfer MJ; Longcope C; Speizer FE
J Natl Cancer Inst; 1995 Sep; 87(17):1297-302. PubMed ID: 7658481
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for breast cancer in women undergoing mammography.
Reuter KL; Baker SP; Krolikowski FJ
AJR Am J Roentgenol; 1992 Feb; 158(2):273-8. PubMed ID: 1729780
[TBL] [Abstract][Full Text] [Related]
16. Plasma prolactin and its relationship to risk factors in human breast cancer.
Kwa HG; Cleton F; de Jong-Bakker M; Bulbrook RD; Hayward JL; Wang DY
Int J Cancer; 1976 Apr; 17(4):441-7. PubMed ID: 945228
[TBL] [Abstract][Full Text] [Related]
17. Plasma prolactin levels in women at postmenopausal age with a family history of breast cancer or a prescription for antihypertensive Rauwolfia treatment.
de Waard F; Kwa HG; Poortman J
Oncology; 1980; 37(1):33-6. PubMed ID: 7350553
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for breast cancer.
Helmrich SP; Shapiro S; Rosenberg L; Kaufman DW; Slone D; Bain C; Miettinen OS; Stolley PD; Rosenshein NB; Knapp RC; Leavitt T; Schottenfeld D; Engle RL; Levy M
Am J Epidemiol; 1983 Jan; 117(1):35-45. PubMed ID: 6823951
[TBL] [Abstract][Full Text] [Related]
19. Plasma prolactin levels in patients with breast cancer.
Rose DP; Pruitt BT
Cancer; 1981 Dec; 48(12):2687-91. PubMed ID: 7306924
[TBL] [Abstract][Full Text] [Related]
20. Sociodemographic factors and pregnancy outcomes associated with prepregnancy obesity: effect modification of parity in the nationwide Epifane birth-cohort.
Boudet-Berquier J; Salanave B; Desenclos JC; Castetbon K
BMC Pregnancy Childbirth; 2017 Aug; 17(1):273. PubMed ID: 28841845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
